Walleye Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87M Buy
240,318
+240,293
+961,172% +$82.3M 0.31% 30
2026
Q1
$8.8K Sell
25
-9,889
-100% -$3.53M ﹤0.01% 4167
2025
Q4
$3.24M Sell
9,914
-5,239
-35% -$1.66M 0.01% 1480
2025
Q3
$4.28M Buy
15,153
+11,783
+350% +$3.42M 0.02% 1022
2025
Q2
$941K Sell
3,370
-2,910
-46% -$824K ﹤0.01% 2100
2025
Q1
$1.96M Sell
6,280
-27,924
-82% -$8.25M 0.01% 1431
2024
Q4
$8.91M Buy
34,204
+23,970
+234% +$7.11M 0.02% 706
2024
Q3
$3.3M Sell
10,234
-9,738
-49% -$3.19M 0.01% 1496
2024
Q2
$6.24M Sell
19,972
-24,186
-55% -$7.11M 0.01% 1123
2024
Q1
$12.6M Buy
+44,158
New +$12.9M 0.02% 695
2021
Q4
Sell
-3,700
Closed -$787K 2082
2021
Q3
$787K Buy
+3,700
New +$852K 0.02% 569
2020
Q2
Sell
-310
Closed -$62K 604
2020
Q1
$62K Sell
310
-500
-62% -$109K 0.01% 664
2019
Q4
$195K Buy
810
+130
+19% +$28.7K 0.01% 1124
2019
Q3
$132K Buy
680
+280
+70% +$53.7K 0.01% 1346
2019
Q2
$74K Buy
+400
New +$71.6K 0.01% 1300

Other funds holding AMGN

Walleye Capital's AMGN Position: Q2 2026 in Review

Walleye Capital increased its Amgen (AMGN) stake by 961,172% in Q2 2026, buying an estimated $82.3M and bringing the position to 240,318 shares worth $87M. The position accounts for 0.31% of the portfolio, ranked #30.

Walleye Capital first reported a position in AMGN in Q2 2019 and has held it in 15 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Walleye Capital held 240,318 shares of Amgen worth $87M as of Q2 2026.
  • Walleye Capital bought 240,293 Amgen shares in Q2 2026, an estimated $82.3M.
  • Amgen made up 0.31% of Walleye Capital's portfolio in Q2 2026, its #30 holding.
  • Walleye Capital first reported a position in Amgen in Q2 2019 and has held it in 15 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.